Resources for Journalists

COVID-19 is a disease caused by the SARS-CoV-2 virus strain, that has not been previously identified in humans. See below for a collection of resources to help you cover this issue (Please note: additional resources are available to journalists who are logged in).

The AusSMC also issues a daily COVID-19 update for registered journalists (click here to view an example). If you would like to receive this email, please go to your profile on MyScimex and select yes beside "Receive COVID-19 Updates?". The email update and this resources page are supported by the Google News Initiative.

Latest COVID-19 news, research, expert reactions and briefings

Show/Hide newsfeed filter Filter by
Type
News for

Choose a location of interest

  1. Priority groups have “worst access” to Covid-19 vaccines in NZ

    Publicly released: Fri 11 Mar 2022 at 0001 AEDT, 0201 NZDT

    New Zealand Medical Journal

    New study shows inequality in vaccine rollout for Māori and at risk communitiesNew Zealand’s rollout of the Covid-19 vaccine has failed Māori and at-risk communities as health officials Read more about Priority groups have “worst access” to Covid-19 vaccines in NZ

    New ZealandUniversity of Waikato | Waikato District Health Board

  2. Improving nano-particle passage through the body

    Publicly released: Thu 10 Mar 2022 at 1530 AEDT, 1730 NZDT

    Nanomaterials

    Acknowledgements: Microscopy Australia at UniSA, ARC, NHMRC and the Alexander von Humboldt Foundation for Fellowship for Experienced Researchers. ... The article, Nanoparticles Surface Chemistry Influence Read more about Improving nano-particle passage through the body

    Australia; International; SAFlinders University

  3. Third dose's a charm: Boosters critical to protect against Omicron

    Publicly released: Thu 10 Mar 2022 at 1030 AEDT, 1230 NZDT

    The BMJ

    Among unvaccinated adults admitted to hospital with covid-19, the delta variant was associated with the most severe disease, followed by the alpha variant and then the omicron variant. ... They conclude: Read more about Third dose's a charm: Boosters critical to protect against Omicron

    InternationalUniversity of Michigan, USA

  4. COVID-19 patients can develop resistance to treatment with Sotrovimab

    Publicly released: Thu 10 Mar 2022 at 0900 AEDT, 1100 NZDT

    New England Journal of Medicine

    Sotrovimab neutralises SARS-CoV-2 predominantly by blocking entry of the virus into the host cell, binding to a particular region of the SARS-CoV-2 spike protein. ... Key findings: The whole genome Read more about COVID-19 patients can develop resistance to treatment with Sotrovimab

    Australia; NSWThe University of Sydney | NSW Health Pathology

  5. COVID-19 booster vaccine recipients were better protected during Qatar's Omicron wave

    Publicly released: Thu 10 Mar 2022 at 0900 AEDT, 1100 NZDT

    New England Journal of Medicine

    The COVID-19 booster vaccines significantly reduce your chances of getting symptomatic Omicron compared to the first two doses, according to research out of Qatar. ... During the country's Omicron wave in Read more about COVID-19 booster vaccine recipients were better protected during Qatar's Omicron wave

    InternationalWeill Cornell Medicine–Qatar

  6. Kids who catch COVID-19 may be less likely than adults to develop antibodies against the virus

    Publicly released: Thu 10 Mar 2022 at 0300 AEDT, 0500 NZDT

    JAMA Network Open

    Kids who catch COVID-19 may be less likely than adults to develop antibodies against the virus, according to Australian research. ... Every article is free online from the day of publication. What The Read more about Kids who catch COVID-19 may be less likely than adults to develop antibodies against the virus

    Australia; VICMurdoch Children's Research Institute (MCRI) | The University of Melbourne ...

  7. University-wide accessibility enhances experiences for students with disability

    Publicly released: Wed 9 Mar 2022 at 1539 AEDT, 1739 NZDT

    The research explored how trained, professional disability support officers and the wider institutional community supported students with disabilities in higher education. ... COVID-19 had a demonstrable Read more about University-wide accessibility enhances experiences for students with disability

    Australia; WACurtin University

  8. The first older COVID-19 patients are experiencing higher levels of cognitive decline

    Publicly released: Wed 9 Mar 2022 at 0300 AEDT, 0500 NZDT

    JAMA Neurology

    COVID-19 patients over 60 who caught the virus in Wuhan early in the pandemic are experiencing higher rates of cognitive decline, according to a study comparing them with their uninfected ... spouses. Read more about The first older COVID-19 patients are experiencing higher levels of cognitive decline

    InternationalThird Military Medical University, China

  9. Most mRNA vaccine side effects aren't serious

    Publicly released: Tue 8 Mar 2022 at 1030 AEDT, 1230 NZDT

    The Lancet Infectious Diseases

    In December 2020 two mRNA COVID-19 vaccines – Pfizer-BioNTech (BNT162b2) and Moderna (mRNA-1723) – were authorised for emergency use in the USA. ... These reports are categorised as non-serious, Read more about Most mRNA vaccine side effects aren't serious

    InternationalCenters for Disease Control and Prevention (CDC), USA

  10. EXPERT REACTION: “Significant” brain changes documented after mild COVID-19

    Publicly released: Tue 8 Mar 2022 at 0300 AEDT, 0500 NZDT

    Nature

    Neurology: Investigating brain changes following COVID-19 Changes to the human brain, including in areas associated with smell and memory, following SARS-CoV-2 infection are described in ... The effects Read more about EXPERT REACTION: “Significant” brain changes documented after mild COVID-19

    Australia; New Zealand; International; NSW; VIC; QLD; WAUniversity of Oxford, University College London, and Imperial College (UK), National Institutes of Health (US)

  11. These genes might make you more likely to end up in hospital if you get COVID-19

    Publicly released: Tue 8 Mar 2022 at 0300 AEDT, 0500 NZDT

    Nature

    Genomics: Genetic factors associated with predisposition for COVID-19 critical illness More than 20 host genetic variants that predispose patients who are infected with SARS-CoV-2 to become Read more about These genes might make you more likely to end up in hospital if you get COVID-19

    Australia; International; QLDThe University of Queensland | University of Edinburgh, UK

  12. This flu season we need to lookout for animal flu viruses that could infect humans and trigger pandemics

    Publicly released: Mon 7 Mar 2022 at 0001 AEDT, 0201 NZDT

    Medical Journal of Australia

    The global COVID-19 pandemic has kept flu at bay for two years, but as borders open, flu is expected to come back into Australia, and we must be on the ... Such efforts will be beneficial beyond influenza: Read more about This flu season we need to lookout for animal flu viruses that could infect humans and trigger pandemics

    Australia; VICWHO Influenza Centre (Australia) | The Peter Doherty Institute for Infection and Immunity ...

  13. Nearly 1 in 10 Kiwis report “excellent” wellbeing in lockdown

    Publicly released: Fri 4 Mar 2022 at 0920 AEDT, 1120 NZDT

    PLOS ONE

    Countering the view that lockdowns are tough for all, a New Zealand survey of 3487 adults has found nine per cent reported excellent wellbeing during 2020’s strict COVID-19 ‘stay ... The team says Read more about Nearly 1 in 10 Kiwis report “excellent” wellbeing in lockdown

    New ZealandUniversity of Otago

  14. Monoclonal antibody bebtelovimab is effective against three Omicron sublineages

    Publicly released: Fri 4 Mar 2022 at 0300 AEDT, 0500 NZDT

    Nature Medicine

    The findings form part of an analysis that suggests that the three sublineages of Omicron are equally divergent from wild-type SARS-CoV-2 and have a similarly comparable effect in ... David Ho and Read more about Monoclonal antibody bebtelovimab is effective against three Omicron sublineages

    InternationalColumbia University, USA

  15. Pfizer vaccine for teens is effective against Delta for up to 4 months

    Publicly released: Fri 4 Mar 2022 at 0300 AEDT, 0500 NZDT

    JAMA Network Open

    Two doses of Pfizer's COVID-19 vaccine remain safe and effective against the Delta strain of COVID for up to 4 months, according to US research. ... The study showed that two doses of the vaccine had high Read more about Pfizer vaccine for teens is effective against Delta for up to 4 months

    InternationalYale School of Medicine, USA

  16. Most children living in out of home care don’t access health services

    Publicly released: Fri 4 Mar 2022 at 0001 AEDT, 0201 NZDT

    Children and Health Services Review

    Dr McLean said access to these services for vulnerable children were even more vital now given the reported impact of COVID-19 on physical and mental health. ... Researchers from The Royal Children’s Read more about Most children living in out of home care don’t access health services

    Australia; VICMurdoch Children's Research Institute (MCRI) | The University of Melbourne

  17. COVID-19 pandemic triggers 25% increase in anxiety and depression worldwide

    Publicly released: Thu 3 Mar 2022 at 1500 AEDT, 1700 NZDT

    In the first year of the COVID-19 pandemic, global prevalence of anxiety and depression increased by 25 per cent, according to a scientific brief released by the World Health Organization ... year of the Read more about COVID-19 pandemic triggers 25% increase in anxiety and depression worldwide

    Australia; InternationalWorld Health Organization (WHO)

  18. WHO recommends Merck's molnupiravir for people at high risk of severe COVID-19

    Publicly released: Thu 3 Mar 2022 at 1415 AEDT, 1615 NZDT

    The BMJ

    sotrovimab for patients with non-severe covid-19 and against the use of convalescent plasma, ivermectin and hydroxychloroquine in patients with covid-19 regardless of disease severity. ... Recommendations Read more about WHO recommends Merck's molnupiravir for people at high risk of severe COVID-19

    Australia; International; VICWorld Health Organization (WHO) | The Royal Melbourne Hospital

  19. COVID-19 widens the gender gap as women bear the brunt of the economic and social impacts

    Publicly released: Thu 3 Mar 2022 at 1345 AEDT, 1545 NZDT

    The Lancet

    However few studies have examined how gender inequalities have been affected by the indirect health, social, and economic effects of the COVID-19 pandemic systematically and in detail across Read more about COVID-19 widens the gender gap as women bear the brunt of the economic and social impacts

    InternationalUniversity of Washington, USA

  20. Booster protection against symptomatic Omicron wanes after 10 weeks

    Publicly released: Thu 3 Mar 2022 at 1245 AEDT, 1445 NZDT

    New England Journal of Medicine

    When it comes to preventing all COVID-19 symptoms, the effectiveness of boosters wanes after 10 weeks, according to a UK study. ... It found that after 20 weeks, two doses of the AstraZeneca vaccine had Read more about Booster protection against symptomatic Omicron wanes after 10 weeks

    InternationalU.K. Health Security Agency

Show Results

  1. 10
  2. 20
  3. 50